Mild cases of COVID-19 give enduring antibody, shows study Kumar Jeetendra | May 24, 2021 Months after recovering from mild cases of COVID-19, people still possess immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all of the while. The …
Immunotherapy treatments for nephrological autoimmune illnesses may help treat serious Coronavirus Kumar Jeetendra | June 8, 2021 Various viruses and bacteria have been known to cause autoimmune diseases where there’s such a predisposition. This phenomenon also seems to play a major part SARS-CoV-2, especially in severe courses. The body’s own immune cells are activated, with the formation of autoantibodies that attack the body’s own healthy cell structures (proteins, autoantigens); deposits of immune …
Analysts study the role of subnuclear NSrp70 in T cell-intervened adaptive immunity Kumar Jeetendra | July 15, 2021 T cell are part of the body’s immune response. The way proteins are spliced in their development and maturation determines how T cells can recognize different pathogens and mount defense against them. Scientists from Korea now highlight the role of NSrp70 in regulating maturation. This protein was previously found in T cells subnuclear space and …
Scientists find how Rift Valley fever virus enters cells Kumar Jeetendra | September 24, 2021 Rift Valley fever virus causes economically tragic hemorrhagic outbreaks in livestock, including cattle, goats, and sheep. The mosquito-borne infections can lead to the spread of infection to people who work with animals that are dying or dead often causing many human infections as well as many deaths. Rift Valley fever, for which there isn’t a …
Study recognizes master regulator behind the improvement of antibody delivering cells Kumar Jeetendra | September 24, 2021 The main regulator that controls the production of antibody-producing cells was identified in a research conducted by scientists from Weill Cornell Medicine. These findings offer new insights into the functioning in the immunity system. It also can help to understand how tissues form and how cancers are triggered. The study, which was published on September. …
Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations Kumar Jeetendra | September 25, 2021 Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit …
Here is a list of the leading 10 pharmaceutical companies in India Kumar Jeetendra | March 2, 2023 India is well-known for establishing a strong foothold in the global pharmaceutical business. It has expanded considerably in recent years. There are over 60,000 generic brands in 60 therapeutic areas. India’s Pharma companies generate about 500 different active pharmaceutical ingredients (APIs). Over 50% of Africa’s need for generic drugs is met by India, as is …
